Drug rebates refer to financial agreements between pharmaceutical manufacturers and payers, such as self-insured employer plans or pharmacy benefit managers (PBMs). These agreements involve a portion of the purchase price of a medication returned to the payer as a rebate or discount after the drug is dispensed to plan members. Drug rebates are commonly used in the pharmacy space to negotiate lower costs on specialty and brand-name drugs and to manage overall plan expenditures.

Drug rebates don’t just impact spend; they apply to several aspects of the pharmacy plan.

Contract Negotiations

Self-insured employer plans and PBMs often negotiate contracts with pharmaceutical manufacturers, including drug rebate provisions. These contracts establish pricing arrangements and rebate terms for specific medications covered under the plan.

Formulary Management

Self-insured employer plans may work with PBMs or other entities to manage the formulary, a list of approved medications. Drug rebates can play a role in formulary decisions, as manufacturers typically offer higher rebates to ensure their products are included on the formulary or receive preferred status.

Cost Savings

When a medication covered by the self-insured employer plan is dispensed, the manufacturer provides a rebate to the plan based on a pre-agreed percentage or amount per unit of the drug. These rebates may reduce the net cost of medications for the self-insured group insurance plan, resulting in cost savings.

Member Out-of-Pocket 

The effect of drug rebates on member costs varies. In some cases, the rebates may lead to lower premiums or reduced out-of-pocket expenses for plan members. However, the specific allocation of rebates and how they are applied to member costs depend on the plan’s design and contract terms. Some plans may use rebates to offset overall plan costs, while others may pass a portion of the rebate savings directly to members.

Transparency and Reporting

Self-insured employer plans should have systems to track and report drug rebates received from pharmaceutical manufacturers. Robust tracking ensures transparency in the rebate process and allows the plan to monitor the financial impact of rebates on medication costs and overall healthcare expenditures.

It’s important to note that the specific arrangements and utilization of drug rebates can vary among self-insured group insurance plans. The extent of rebate negotiations, the drugs eligible for rebates, and how the rebate savings are allocated can depend on the plan’s contractual agreements, formulary management, and overall pricing strategies.

Prescription Care Management (PCM) is a health tech company dedicated to simplifying pharmacyand medical plan management for brokers and plan sponsors. With plan-specific analytics and insights, PCM’s Performance tool validates contract spend, guarantees, and rebates with a few clicks. To learn more about partnering with PCM, click here.